Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fonar Corporation stock logo
FONR
Fonar
$16.05
+6.5%
$15.51
$12.00
$17.62
$99.48M0.9718,990 shs60,290 shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$2.40
-0.4%
$2.45
$1.99
$3.80
$100.13M0.68104,136 shs96,125 shs
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$2.56
+3.0%
$2.69
$2.20
$6.50
$98.73M0.61289,636 shs123,891 shs
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$3.00
-3.3%
$4.20
$1.98
$7.95
$22.40M7.02389,924 shs160,565 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fonar Corporation stock logo
FONR
Fonar
-0.59%-1.57%-5.76%-2.27%-6.98%
InspireMD, Inc. stock logo
NSPR
InspireMD
-0.41%+0.42%-1.23%+8.07%-9.74%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
+0.81%+5.53%-9.16%-13.89%-51.75%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-0.96%-7.74%-28.41%-19.06%+18.77%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fonar Corporation stock logo
FONR
Fonar
$16.05
+6.5%
$15.51
$12.00
$17.62
$99.48M0.9718,990 shs60,290 shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$2.40
-0.4%
$2.45
$1.99
$3.80
$100.13M0.68104,136 shs96,125 shs
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$2.56
+3.0%
$2.69
$2.20
$6.50
$98.73M0.61289,636 shs123,891 shs
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$3.00
-3.3%
$4.20
$1.98
$7.95
$22.40M7.02389,924 shs160,565 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fonar Corporation stock logo
FONR
Fonar
-0.59%-1.57%-5.76%-2.27%-6.98%
InspireMD, Inc. stock logo
NSPR
InspireMD
-0.41%+0.42%-1.23%+8.07%-9.74%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
+0.81%+5.53%-9.16%-13.89%-51.75%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-0.96%-7.74%-28.41%-19.06%+18.77%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fonar Corporation stock logo
FONR
Fonar
0.00
N/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
3.00
Buy$4.5087.50% Upside
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
3.00
Buy$13.50428.38% Upside
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
2.50
Moderate Buy$4.9264.00% Upside

Current Analyst Ratings Breakdown

Latest VVOS, NSPR, FONR, and OBIO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/9/2025
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$6.20 ➝ $6.50
9/4/2025
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$12.00 ➝ $10.00
8/20/2025
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuyNeutral
8/13/2025
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
Chardan Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$20.00
8/7/2025
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
Chardan Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$20.00
(Data available from 10/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fonar Corporation stock logo
FONR
Fonar
$104.35M0.95$2.23 per share7.21$25.81 per share0.62
InspireMD, Inc. stock logo
NSPR
InspireMD
$7.07M14.17N/AN/A$1.83 per share1.31
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$2.64M37.40N/AN/A$0.87 per share2.94
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$14.39M1.56N/AN/A$1.35 per share2.22
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fonar Corporation stock logo
FONR
Fonar
$8.33M$1.2313.04N/A7.99%5.22%3.91%N/A
InspireMD, Inc. stock logo
NSPR
InspireMD
-$19.92M-$0.83N/AN/AN/A-413.96%-69.42%-57.68%N/A
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
-$61.02M-$1.83N/AN/AN/A-2,367.49%-289.42%-110.04%11/11/2025 (Estimated)
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$11.14M-$1.68N/AN/AN/A-99.49%-232.76%-84.30%11/13/2025 (Estimated)

Latest VVOS, NSPR, FONR, and OBIO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/22/2025Q4 2025
Fonar Corporation stock logo
FONR
Fonar
N/A$0.11N/A$0.11N/A$27.28 million
8/19/2025Q2 2025
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$0.39-$0.55-$0.16-$0.55$3.37 million$3.82 million
8/12/2025Q2 2025
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
-$0.51-$0.50+$0.01-$0.50$0.78 million$0.84 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Fonar Corporation stock logo
FONR
Fonar
N/AN/AN/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
N/AN/AN/AN/AN/A
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
N/AN/AN/AN/AN/A
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fonar Corporation stock logo
FONR
Fonar
N/A
8.45
8.28
InspireMD, Inc. stock logo
NSPR
InspireMD
N/A
6.39
6.05
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
48.76
2.10
2.09
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
1.69
1.05
1.05

Institutional Ownership

CompanyInstitutional Ownership
Fonar Corporation stock logo
FONR
Fonar
50.64%
InspireMD, Inc. stock logo
NSPR
InspireMD
44.78%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
53.20%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
26.35%

Insider Ownership

CompanyInsider Ownership
Fonar Corporation stock logo
FONR
Fonar
1.55%
InspireMD, Inc. stock logo
NSPR
InspireMD
34.06%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
8.10%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
3.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Fonar Corporation stock logo
FONR
Fonar
4806.20 million6.11 millionNot Optionable
InspireMD, Inc. stock logo
NSPR
InspireMD
5041.72 million18.33 millionOptionable
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
438.64 million35.51 millionNot Optionable
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
1607.51 million7.28 millionOptionable

Recent News About These Companies

Vivos Reports 7% Sales Drop

New MarketBeat Followers Over Time

Media Sentiment Over Time

Fonar stock logo

Fonar NASDAQ:FONR

$16.05 +0.99 (+6.54%)
As of 02:55 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

InspireMD stock logo

InspireMD NYSE:NSPR

$2.40 -0.01 (-0.41%)
As of 02:56 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Orchestra BioMed stock logo

Orchestra BioMed NASDAQ:OBIO

$2.56 +0.08 (+3.02%)
As of 02:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

Vivos Therapeutics stock logo

Vivos Therapeutics NASDAQ:VVOS

$3.00 -0.10 (-3.29%)
As of 02:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.